Treatment Decisions in Advanced Ovarian Cancer
Author Information
Author(s): M.M. Cody, M.L. Slevin
Primary Institution: St Bartholomew's and Homerton Hospitals
Conclusion
The editorial discusses the complexities and challenges in making treatment decisions for patients with advanced ovarian cancer, emphasizing the need for a more rational approach to patient selection for phase II trials.
Supporting Evidence
- Many patients with advanced cancer are willing to undergo intensive treatment even if the chance of benefit is low.
- Patient satisfaction is not always linked to objective tumor response, as some patients value the hope of treatment.
- Decisions about treatment should involve open discussions between doctors and patients, considering the patient's quality of life.
Takeaway
Doctors have a tough job deciding how to treat women with advanced ovarian cancer because many treatments might not help, but patients still want to try them for a chance to feel better.
Potential Biases
There may be biases in how patients perceive treatment options and their willingness to undergo potentially ineffective therapies.
Limitations
The editorial does not provide specific data or studies to support its claims, relying instead on general observations and previous research.
Want to read the original?
Access the complete publication on the publisher's website